KRMD Stock Analysis: Buy, Sell, or Hold?
KRMD - KORU Medical Systems, Inc. Common Stock (DE)
$3.17
0.09 (3.09%)
â˛
5d:
+5.67%
30d:
-3.06%
90d:
-22.3%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 11, 2026
18d
Get Alerted When KRMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: KRMD is fairly priced but lacks strong directional signals. At -18.1% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: KRMD is fairly priced but lacks strong directional signals. At -18.1% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: KRMD is currently trading at $3.17, which is considered slightly high relative to its 30-day fair value range of $2.98 to $3.20. From a valuation perspective, the stock is trading at a discount (Forward PE: 87.9) compared to its historical average (159.8). Remarkably, the market is currently pricing in an annual earnings decline of 18.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, KRMD is in a strong downtrend. The price is approaching resistance at $3.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $6.25 (+103.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KRMD is in a strong downtrend. The price is approaching resistance at $3.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $6.25 (+103.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.98 -
$3.20
Company Quality Score
39/100
(SELL)
Options IV Signal
31th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- NEUTRAL: Options fairly priced (IV 31th percentile)
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.1%)
- BULLISH: Trading 103.3% below Wall St target ($6.25)
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.98 -
$3.20
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
Âą$0.48
(15.2%)
Support & Resistance Levels
Support Level
$2.87
Resistance Level
$3.19
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
87.86
Wall Street Target
$6.25
(+103.3%)
Revenue Growth (YoY)
18.2%
Earnings Growth (YoY)
-66.0%
Profit Margin
-4.0%
Valuation Discount vs History
-18.1% cheaper
PE vs Historical
87.9 vs 159.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-18.1%
(market-implied from PE analysis)
1-Year Target
$2.77
(-10%)
2-Year Target
$2.49
(-19%)
3-Year Target
$2.24
(-27%)
3-Yr Target (if PE normalizes)
(PE: 88â160)
$4.08
(+33%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 87.9 to 159.8
Stabilization Target:
$5.59
(+81.9%)
PE Expansion Potential:
+81.9%
Share & Embed Analysis
Last updated: October 23, 2026 3:41 PM ET
Data refreshes hourly during market hours. Next update: 4:41 PM
Data refreshes hourly during market hours. Next update: 4:41 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KRMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$479 | 37 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$83 | 43 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
22 analysts |
$198 | 57 HOLD |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
17 analysts |
$413 | 37 SELL |
|
STVN
Stevanato Group SpA |
BUY
14 analysts |
$24 | 72 BUY |
